Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Front Immunol. 2023 Aug 14;14:1226443. doi: 10.3389/fimmu.2023.1226443. eCollection 2023.
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous myeloid cell population and serve as a vital contributor to the tumor microenvironment. Reactive oxygen species (ROS) are byproducts of aerobic respiration and are involved in regulating normal biological activities and disease progression. MDSCs can produce ROS to fulfill their immunosuppressive activity and eliminate excessive ROS to survive comfily through the redox system. This review focuses on how MDSCs survive and function in high levels of ROS and summarizes immunotherapy targeting ROS in MDSCs. The distinctive role of ROS in MDSCs will inspire us to widely apply the blocked oxidative stress strategy in targeting MDSC therapy to future clinical therapeutics.
髓系来源的抑制细胞(MDSCs)是一种异质性的髓系细胞群体,是肿瘤微环境的重要贡献者。活性氧(ROS)是有氧呼吸的副产物,参与调节正常的生物学活动和疾病进展。MDSCs 可以产生 ROS 来发挥其免疫抑制活性,并通过氧化还原系统清除过多的 ROS 以舒适地生存。本综述重点关注 MDSCs 如何在高 ROS 水平下生存和发挥功能,并总结了针对 MDSC 中 ROS 的免疫疗法。ROS 在 MDSCs 中的独特作用将激励我们在未来的临床治疗中广泛应用针对 MDSC 治疗的阻断氧化应激策略。